Current treatment of sudden deafness

Abstract

Sudden deafness, also known as sudden sensorineural deafness, is a rapid decline in auditory function that requires immediate management. The pathogenesis of sudden deafness is not clear, only about 10 - 15% can find the cause. There are different treatments for idiopathic sudden deafness such as systemic corticosteroids, vasodilators, antioxidants and blood viscosity modifiers. This study was conducted with the goal of reviewing current treatments for sudden deafness. The results obtained are varied and lack clear conclusions. Systemic oral corticosteroids at a dose of prednisolone of 1mg/kg are still considered first-line options. Transtympanic corticosteroid injections are used in the initial measure if systemic corticosteroids are contraindicated or salvage therapy follows systemic therapy. Hyperbaric oxygen therapy should be used when the patient is severely deaf and late to treatment. Other therapies such as vasodilators, antivirals ... not recommended. Other measures such as posterior tympanotomy with round window drilling and steroid instillation, neurological rehabilitation therapy are being studied.